99.Ip MS, Lam B, Chan LY, et al: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166-2171, 2000.
100.Imadojemu VA, Gleeson K, Quraishi SA, et al: Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165:950-953, 2002.
101.Ip MSM, Tse HF, Lam B, et al: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348-353, 2004.
102.Nieto FJ, Herrington DM, Redline S, et al: Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354-360, 2004.
103.Brooks D, Horner RL, Kozar LF, et al: Obstructive sleep apnea as a cause of systemic hypertension: Evidence from a canine model. J Clin Invest 99:106-109, 1997.
104.Buda AJ, Pinsky MR, Ingels NBJ, et al: Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 301:453-459, 1979.
105.Bradley TD, Holloway RM, McLaughlin PR, et al: Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 145:377-382, 1992.
106.Malone S, Liu PP, Holloway R, et al: Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 338:1480-1484, 1991.
107.Scharf SM, Bianco JA, Tow DE, et al: The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary artery disease. Circulation 63:871-875, 1981.
108.Parker JD, Brooks D, Kozar LF, et al: Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160:1888-1896, 1999.
109.Buda AJ, Schroeder JS, Guilleminault C: Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol 1:67-74, 1981.
110.Peters J, Fraser C, Stuart RS, et al: Negative intrathoracic pressure decreases independently left ventricular filling and emptying. Am J Physiol 257:H120-H131, 1989.
111.Virolainen J, Ventila M, Turto H, et al: Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 79:455-460, 1995.
112.Hall MJ, Ando SI, Floras JS, et al: Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 85:1476-1484, 1998.
113.Hanly P, Sasson Z, Zuberi N, et al: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71:1341-1345, 1993.
114.Chaudhary BA, Ferguson DS, Speir WA: Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 82:122-124, 1982.
115.Chan HS, Chiu HF, Tse LK, et al: Obstructive sleep apnea presenting with nocturnal angina, heart failure, and near-miss sudden death. Chest 99:1023-1025, 1991.
116.Franklin KA, Nilsson JB, Sahlin C: Sleep apnoea and nocturnal angina. Lancet 345:1085-1087, 1995.
117.Cargill RI, Kiely DG, Lipworth BJ: Adverse effects of hypoxemia on diastolic filling in humans. Clin Sci 89:165-169, 1995.
118.Tolle FA, Judy WV, Yu PL, et al: Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55:1718-1724, 1983.
119.Stoohs R, Guilleminault C: Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 72:583-589, 1992.
120.Somers VK, Mark AL, Zavala DC, et al: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67:2101-2106, 1989.
121.Galatius-Jensen S, Hansen J, Rasmussen V, et al: Nocturnal hypoxaemia after myocardial infarction: Association with nocturnal myocardial ischaemia and arrhythmias. Br Heart J 72:23-30, 1994.
122.Shepard JW Jr, Garrison MW, Guther DA, et al: Relationship of ventricular ectopy to nocturnal O2 desaturation in patients with obstructive sleep apnea. Chest 88:325-340, 1985.
123.Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 82(Suppl I):I-35-I-43, 1990.
124.Seppala T, Partinen M, Penttila A, et al: Sudden death and sleeping history among Finnish men. J Intern Med 229:23-28, 1991.
125.Hender J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea. J Hypertens 8:941-946, 1990.
126.Hanly P, Sasson Z, Zuberi N, et al: Ventricular function in snorers and patients with obstructive sleep apnea. Chest 102:100-105, 1992.
127.Amin R, Kimball T, Bean J, et al: Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165:1395-1399, 2002.
128.Kaneko Y, Floras JS, Usui K, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241, 2003.
129.Mansfield DR, Gollogly NC, Kaye DM, et al: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361-366, 2004.
130.Kaye DM, Lambert GM, Lefkovits J, et al: Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 23:570-578, 1994.
131.Cohn JN, Levine TB, Olivary MT, et al: Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819-823, 1984.
132.Sanner BM, Konermann M, Tepel M, et al: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:648-652, 2000.
133.Bokinsky G, Miller M, Ault K, et al: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: A preliminary investigation. Chest 108:625-630, 1995.
134.Nobili L, Schiavi G, Bozano E, et al: Morning increase in whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-27, 2000.
135.Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464, 2002.
136.Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570, 2000.
137.Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-939, 2002.
138.Lavie L, Kraiczi H, Hefetz A, et al: Plasma vascular endothelial growth factor in sleep apnea syndrome: Effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165:1624-1628, 2002.
139.Ip MS, Lam B, Ng MMT, et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676, 2002.
140.Punjabi NM, Sorkin JD, Karzel LI, et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682, 2002.
141.Chin K, Shimizu K, Nakamura T, et al: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712, 1999.
142.Harsch IA, Schahin SP, Radespiel-Troger M, et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162, 2004.
143.Bradley TD, Rutherford R, Grossman RF, et al: Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131:835-839, 1985.
